Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2020-03-12 AGM Information
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) filed with the Korean regulatory authority (KRX). It details the agenda for an upcoming Annual General Meeting (AGM), including items such as financial statement approval, director appointments, and amendments to the articles of incorporation. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items for their vote. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2020-03-12 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Cellumed. It contains the agenda, meeting details, and management reference materials (business overview, industry status, etc.) required by law to be provided to shareholders before the meeting. This document is a standard proxy statement/information circular used to solicit votes and inform shareholders of the upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-12 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal notification filed by Cellumed regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the reasoning for the date selection and mentions the implementation of electronic voting. Since this is a regulatory disclosure regarding the logistics of a shareholder meeting rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2020-02-28 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Cellumed. It outlines the date, location, and specific agenda items for the upcoming meeting, including the approval of financial statements, changes to the articles of incorporation, and the appointment of directors and auditors. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2020-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Cellumed) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea (DART system) to inform the market of material financial shifts before the final audit is completed. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the variance. FY 2019
2020-02-27 Korean
기타경영사항(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) from Cellumed regarding the voluntary lock-up (의무보유) of shares held by the largest shareholder (Inscobee) and company directors. This type of corporate announcement regarding shareholding restrictions and management stability does not fit into specific categories like director dealings (which are individual trades) or major shareholding notifications (which are about threshold changes). As it is a general regulatory announcement regarding corporate management and share status, it falls under the RNS (Regulatory Filings) category.
2020-02-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.